These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 21226860)

  • 1. Erythropoietin administration is associated with short-term improvement in glomerular filtration rate after ischemia-reperfusion injury.
    Sølling C; Christensen AT; Krag S; Frøkiaer J; Wogensen L; Krog J; Tønnesen EK
    Acta Anaesthesiol Scand; 2011 Feb; 55(2):185-95. PubMed ID: 21226860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erythropoietin does not attenuate renal dysfunction or inflammation in a porcine model of endotoxemia.
    Sølling C; Christensen AT; Nygaard U; Krag S; Frøkiaer J; Wogensen L; Krog J; Tønnesen EK
    Acta Anaesthesiol Scand; 2011 Apr; 55(4):411-21. PubMed ID: 21342148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effects of caspase inhibitors on the renal dysfunction and injury caused by ischemia-reperfusion of the rat kidney.
    Chatterjee PK; Todorovic Z; Sivarajah A; Mota-Filipe H; Brown PA; Stewart KN; Cuzzocrea S; Thiemermann C
    Eur J Pharmacol; 2004 Oct; 503(1-3):173-83. PubMed ID: 15496312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased progression to kidney fibrosis after erythropoietin is used as a treatment for acute kidney injury.
    Gobe GC; Bennett NC; West M; Colditz P; Brown L; Vesey DA; Johnson DW
    Am J Physiol Renal Physiol; 2014 Mar; 306(6):F681-92. PubMed ID: 24402097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal oxygenation in acute renal ischemia-reperfusion injury.
    Abdelkader A; Ho J; Ow CP; Eppel GA; Rajapakse NW; Schlaich MP; Evans RG
    Am J Physiol Renal Physiol; 2014 May; 306(9):F1026-38. PubMed ID: 24598805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erythropoietin and acute renal failure.
    Sharples EJ; Yaqoob MM
    Semin Nephrol; 2006 Jul; 26(4):325-31. PubMed ID: 16949472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-acetylcysteine attenuates kidney injury in rats subjected to renal ischaemia-reperfusion.
    Nitescu N; Ricksten SE; Marcussen N; Haraldsson B; Nilsson U; Basu S; Guron G
    Nephrol Dial Transplant; 2006 May; 21(5):1240-7. PubMed ID: 16390850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic and renal haemodynamic changes in renal schemia/reperfusion injury: impact of erythropoietin.
    Hussein AA; Barakat N; Awadalla A; Shokeir AA
    Can J Physiol Pharmacol; 2012 Nov; 90(11):1535-43. PubMed ID: 23181281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of N-acetyl-L-cysteine on renal haemodynamics and function in early ischaemia-reperfusion injury in rats.
    Nitescu N; Grimberg E; Ricksten SE; Guron G
    Clin Exp Pharmacol Physiol; 2006; 33(1-2):53-7. PubMed ID: 16445699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of K-ATP channel blockage during erythropoietin treatment in renal ischemia-reperfusion injury.
    Yazihan N; Ataoglu H; Kavas GO; Akyurek N; Yener B; Aydm C
    J Invest Surg; 2008; 21(6):340-7. PubMed ID: 19160144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pravastatin, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, attenuates renal injury in an experimental model of ischemia-reperfusion.
    Joyce M; Kelly C; Winter D; Chen G; Leahy A; Bouchier-Hayes D
    J Surg Res; 2001 Nov; 101(1):79-84. PubMed ID: 11676559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective effects of peroxisome proliferator-activated receptor gamma ligand on apoptosis and hepatocyte growth factor induction in renal ischemia-reperfusion injury.
    Doi S; Masaki T; Arakawa T; Takahashi S; Kawai T; Nakashima A; Naito T; Kohno N; Yorioka N
    Transplantation; 2007 Jul; 84(2):207-13. PubMed ID: 17667812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recovery from ischemic acute kidney injury by spironolactone administration.
    Sánchez-Pozos K; Barrera-Chimal J; Garzón-Muvdi J; Pérez-Villalva R; Rodríguez-Romo R; Cruz C; Gamba G; Bobadilla NA
    Nephrol Dial Transplant; 2012 Aug; 27(8):3160-9. PubMed ID: 22516623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant human erythropoietin protects the liver from hepatic ischemia-reperfusion injury in the rat.
    Sepodes B; Maio R; Pinto R; Sharples E; Oliveira P; McDonald M; Yaqoob M; Thiemermann C; Mota-Filipe H
    Transpl Int; 2006 Nov; 19(11):919-26. PubMed ID: 17018128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exogenous surfactant attenuation of ischemia-reperfusion injury in the lung through alteration of inflammatory and apoptotic factors.
    van Putte BP; Cobelens PM; van der Kaaij N; Lachmann B; Kavelaars A; Heijnen CJ; Kesecioglu J
    J Thorac Cardiovasc Surg; 2009 Apr; 137(4):824-8. PubMed ID: 19327503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Renal protective effects of erythropoietin on ischemic reperfusion injury].
    Moriyama M; Tanaka T; Suzuki K
    Hinyokika Kiyo; 2010 Aug; 56(8):473-9. PubMed ID: 20808070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urotensin-II receptor antagonism does not improve renal haemodynamics or function in rats with endotoxin-induced acute kidney injury.
    Nitescu N; Grimberg E; Guron G
    Clin Exp Pharmacol Physiol; 2010 Dec; 37(12):1170-5. PubMed ID: 20880186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of warm ischemic time on renal function and injury in the isolated hemoperfused kidney.
    Harper SJ; Hosgood SA; Waller HL; Yang B; Kay MD; Goncalves I; Nicholson ML
    Transplantation; 2008 Aug; 86(3):445-51. PubMed ID: 18698249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Theophylline improves early allograft function in rat kidney transplantation.
    Grenz A; Baier D; Petroktistis F; Wehrmann M; Köhle C; Schenk M; Sessler M; Gleiter CH; Fandrich F; Osswald H
    J Pharmacol Exp Ther; 2006 May; 317(2):473-9. PubMed ID: 16410406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatocyte growth factor ameliorates renal hemodynamic disorder after ischemia/reperfusion.
    Nakatani T; Kim T; Uchida J; Kumata N; Kawashima H; Sugimura K
    Int J Mol Med; 2002 Aug; 10(2):217-9. PubMed ID: 12119562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.